bso glutathione depletion Buthionine Sulfoximine - an overview Glutathione depletion by BSO promotes

Continued investigations into synergistic regimens, targeted drug delivery, and clinical safety profiles are of utmost importance for fully realizing artemisinins therapeutic potential in cancer treatments

UBT251 is one of those candidates, along with oral and subcutaneous formulations of amylin and GLP-1 agonist amycretin and its recently launched oral formulation of Wegovy, which has started well in the US market, but could face competition from Lilly's oral GLP-1 agonist orforglipron within the next few weeks

This neuroprotective suppression of glutamate release is mediated by Ca++ channels (P/Q type), a step which is modulated by pkc and not pka

Miyamoto H, Saura R, Doita M, Kurosaka M, Mizuno K